Seamless Oncology Olive AI Replacement for Prior Authorization

The Imperative for Oncology Olive AI Replacement

Oncology prior authorization is inherently complex, driven by high-cost biologics, intricate chemotherapy regimens, advanced imaging, and frequent treatment modifications. The need for a reliable, specialized prior authorization platform has become even more critical for organizations impacted by the Olive AI shutdown, demanding a strategic oncology Olive AI replacement to safeguard patient care and revenue cycles.

Unique Prior Authorization Challenges in Oncology

• **High-Volume PA Categories:** Frequent PAs for J-code chemotherapy and biologic infusions, advanced imaging (PET/CT, MRI), radiation oncology procedures (IMRT, SBRT), and specialty oral oncolytics.
• **NCCN Guideline Adherence:** Strict adherence to NCCN Clinical Practice Guidelines and the NCCN Drugs & Biologics Compendium for medical necessity and off-label drug use.
• **Regimen-Level Complexity:** PAs often cover multiple drugs within a single regimen, with frequent changes due to toxicity or disease progression, leading to dozens of PA events per patient.
• **Urgency of Care:** Critical diagnosis-to-treatment intervals for many cancers mean PA delays directly impact patient outcomes, requiring rapid turnaround times.
• **Benefit Split:** Navigating separate PA pathways for medical benefit (IV therapies via X12 278 or payer portals) and pharmacy benefit (oral oncolytics via PBMs and ePA partners like CoverMyMeds or Surescripts).

Klivira's Solution for Oncology Prior Authorization Automation

Klivira offers a comprehensive, specialty-tuned prior authorization automation platform designed to meet the rigorous demands of cancer care. Our solution provides a seamless oncology Olive AI replacement, leveraging advanced logic and deep integration capabilities to streamline PA workflows, reduce denials, and accelerate time to treatment for your patients.

Klivira's Oncology-Specific Prior Authorization Capabilities

• **NCCN-Compendium-Aware Policy Logic:** Automates documentation requirements based on NCCN guidelines, tumor staging, molecular markers, and prior-line therapy, reducing documentation gaps.
• **Regimen-Level PA Workflow:** Bundles related chemotherapy, targeted therapy, and immunotherapy components into single submissions where supported by payers, or manages iterative submissions as needed.
• **Intelligent Benefit Routing:** Automatically directs medical benefit PAs (e.g., J-codes) to payer portals or X12 278, and pharmacy benefit PAs (e.g., oral oncolytics) to appropriate PBM and ePA channels.
• **Concurrent PA Tracking:** Manages the dozens of PA events per patient, from initial diagnosis and staging to treatment changes, supportive care (e.g., G-CSF), and surveillance imaging.
• **Peer-to-Peer Scheduling Integration:** Facilitates efficient scheduling and documentation transfer for clinical-necessity denials that require oncologist-payer peer-to-peer reviews.

Seamless Integration and Data Flow

Klivira integrates directly with your existing EMR system via SMART on FHIR, ensuring bi-directional data exchange for patient demographics, clinical notes, pathology reports, and order details. This deep integration eliminates manual data entry, provides real-time status updates within your EMR, and ensures that all necessary documentation for oncology PAs, including AJCC TNM staging and molecular marker results, is accurately submitted.

Navigating Your Migration to Klivira

Transitioning from a previous automation platform requires careful planning. Klivira's dedicated implementation team provides expert guidance through every step of your oncology Olive AI replacement, from initial data migration to system configuration and user training. Our goal is to ensure a smooth, efficient transition with minimal disruption to your critical oncology workflows, allowing your team to maintain focus on patient care.